The Clinical Characteristics and Prognosis of Patients With Anthracycline-Induced Cardiomyopathy

被引：0
|
作者：
Thomas, Garry R.
Siu, Vince
McDonald, Michael A.
Ross, Heather J.
Delgado, Diego H.
Billia, Filio
Rao, Vivek
Amir, Eitan
Thavendiranathan, Paaladinesh
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Cardiomyopathy; Ventricular function; Heart failure; adult; Cardiooncology;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18687
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
    Nettersheim, Felix Sebastian
    Schlueter, Johannes David
    Kreuzberg, Wiebke
    Mehrkens, Dennis
    Grimm, Simon
    Nemade, Harshal
    Braumann, Simon
    Hof, Alexander
    Guthoff, Henning
    Peters, Vera
    Hoyer, Friedrich Felix
    Kargapolova, Yulia
    Lackmann, Jan-Wilm
    Mueller, Stefan
    Pallasch, Christian P.
    Hallek, Michael
    Sachinidis, Agapios
    Adam, Matti
    Winkels, Holger
    Baldus, Stephan
    Geissen, Simon
    Mollenhauer, Martin
    BASIC RESEARCH IN CARDIOLOGY, 2023, 118 (01)
  • [22] Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy
    Ghasem Janbabai
    Maryam Nabati
    Mohsen Faghihinia
    Soheil Azizi
    Samaneh Borhani
    Jamshid Yazdani
    Cardiovascular Toxicology, 2017, 17 : 130 - 139
  • [23] Is Bilirubin Protective Against Anthracycline-induced Cardiomyopathy?
    Vera, Trinity
    Morgan, Timothy M.
    Jordan, Jennifer H.
    Whitlock, Matthew C.
    Kitzman, Dalane
    Hundley, W. G.
    CIRCULATION, 2014, 130
  • [24] Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy
    Janbabai, Ghasem
    Nabati, Maryam
    Faghihinia, Mohsen
    Azizi, Soheil
    Borhani, Samaneh
    Yazdani, Jamshid
    CARDIOVASCULAR TOXICOLOGY, 2017, 17 (02) : 130 - 139
  • [25] Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms
    Dadson, Keith
    Calvillo-Arguelles, Oscar
    Thavendiranathan, Paaladinesh
    Billia, Filio
    CLINICAL SCIENCE, 2020, 134 (13) : 1859 - 1885
  • [26] Anthracycline-induced cardiomyopathy in a dog treated with epirubicin
    Lee, Ye-Rin
    Kang, Min-Hee
    Park, Hee-Myung
    CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 2015, 56 (06): : 571 - 574
  • [27] Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
    Acar, Zeydin
    Kale, Abdurrahman
    Turgut, Mehmet
    Demircan, Sabri
    Durna, Kenan
    Demir, Serdar
    Meric, Murat
    Agac, Mustafa Tarik
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (09) : 988 - 989
  • [28] Cardiac resynchronisation therapy in anthracycline-induced cardiomyopathy
    Patel, Divyang
    Kumar, Anirudh
    Moennich, Laurie Ann
    Trulock, Kevin
    Nemer, David M.
    Donnellan, Eoin
    Il'Giovine, Zachary J.
    Martyn, Trejeeve
    Callahan, Thomas D.
    Hussein, Ayman A.
    Tarakji, Khaldoun G.
    Kanj, Mohamed
    Cantillon, Daniel J.
    Baranowski, Bryan
    Starling, Randall C.
    Tang, W. H. Wilson
    Wazni, Oussama M.
    Varma, Niraj
    Wilkoff, Bruce L.
    Rickard, John
    HEART, 2022, 108 (04) : 274 - 278
  • [29] Proteomic analysis in the study of anthracycline-induced cardiomyopathy
    Lenco, J.
    Sterba, M.
    Mazurova, Y.
    Popelova, O.
    Brychta, M.
    Stulik, J.
    Gersl, V.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S83 - S83
  • [30] Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
    Felix Sebastian Nettersheim
    Johannes David Schlüter
    Wiebke Kreuzberg
    Dennis Mehrkens
    Simon Grimm
    Harshal Nemade
    Simon Braumann
    Alexander Hof
    Henning Guthoff
    Vera Peters
    Friedrich Felix Hoyer
    Yulia Kargapolova
    Jan-Wilm Lackmann
    Stefan Müller
    Christian P. Pallasch
    Michael Hallek
    Agapios Sachinidis
    Matti Adam
    Holger Winkels
    Stephan Baldus
    Simon Geißen
    Martin Mollenhauer
    Basic Research in Cardiology, 118
12345